Aroa Biosurgery Ltd

ARX

Company Profile

  • Business description

    Aroa Biosurgery Ltd is a soft tissue regeneration company that develops, manufactures, and sells medical devices for wound and soft tissue repair using its proprietary extracellular matrix (ECM) technology. It is focused on improving the rate and quality of healing in complex wounds and soft tissue reconstruction. The company is in the business of developing, manufacturing, and selling soft tissue repair products. The company's principal market is the United States, where it has five key products for sale targeting chronic wounds, hernia, plastics, reconstructive surgery, and trauma/limb salvage/tumor surgery.

  • Contact

    64 Richard Pearse Drive
    Mangere, Airport Oaks
    Auckland2022
    NZL

    T: +64 98693035

    https://www.aroa.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 March 2027

    Employees

    249

Stocks News & Analysis

stocks

Corning’s AI fiber boom is real, but its stock price may be getting out of hand

Corning’s optical fiber business is thriving, and the Meta deal derisks its supply buildout, but success isn’t guaranteed.
stocks

Going into earnings, is Alphabet stock a buy, a sell, or fairly valued?

From AI integration to capital expenditure increases, here’s what we expect in Alphabet’s earnings report.
stocks

ASX energy share remains cheap despite strong outlook

Santos reports a solid quarter on the back of higher commodity prices - yet the shares look undervalued.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,935.0014.40-0.16%
CAC 408,112.9229.00-0.36%
DAX 4024,033.1550.38-0.21%
Dow JONES (US)49,149.7818.01-0.04%
FTSE 10010,310.4110.68-0.10%
HKSE25,679.78245.87-0.95%
NASDAQ24,700.74186.36-0.75%
Nikkei 22559,917.46619.90-1.02%
NZX 50 Index12,764.40110.54-0.86%
S&P 5007,139.9933.92-0.47%
S&P/ASX 2008,710.7010.50-0.12%
SSE Composite Index4,078.647.71-0.19%

Market Movers